Tag Archives: Genomic Health

What Made Canaccord Genuity Downgrade Genomic Health’s Stock?

Genomic Health (GHDX – Research Report) received a Hold rating and a $72 price target from Canaccord Genuity analyst Mark Massaro yesterday. The company’s shares closed yesterday at $73.07. Massaro wrote: “We are also lowering our price target from $77

What Did This CEO Just Do with Personal Shares of Genomic Health (NASDAQ: GHDX)?

Yesterday, the President & CEO of Genomic Health (GHDX – Research Report), Kimberly Popovits, sold shares of GHDX for $166.5K. This is Popovits’ first Sell trade following 9 Buy transactions. In addition to Kimberly Popovits, one other GHDX executive reported

The CSO of Genomic Health (NASDAQ: GHDX) is Buying Shares

Today, the CSO of Genomic Health (GHDX – Research Report), Steven Shak, bought shares of GHDX for $911.6K. This recent transaction increases Steven Shak’s holding in the company by 9.91% to a total of $25.66 million. In addition to Steven

The CSO of Genomic Health (NASDAQ: GHDX) is Selling Shares

Today, the CSO of Genomic Health (GHDX – Research Report), Steven Shak, sold shares of GHDX for $15.56K. In addition to Steven Shak, 5 other GHDX executives reported Sell trades in the last month. This is Shak’s first Sell trade

The CCO of Genomic Health is Exercising Options

Yesterday it was reported that the CCO of Genomic Health (GHDX – Research Report), James J. Vaughn, exercised options to buy 2,222 GHDX shares at $28.73 a share, for a total transaction value of $63.85K. Following this transaction James J.

The CFO of Genomic Health (NASDAQ: GHDX) is Buying Shares

Today, the CFO of Genomic Health (GHDX – Research Report), Bradley Cole, bought shares of GHDX for $315.7K. Following Bradley Cole’s last GHDX Buy transaction on December 09, 2014, the stock climbed by 36.7%. Following this transaction Bradley Cole’s holding